Jacqueline McDermott

635 total citations
20 papers, 370 citations indexed

About

Jacqueline McDermott is a scholar working on Reproductive Medicine, Oncology and Immunology. According to data from OpenAlex, Jacqueline McDermott has authored 20 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Reproductive Medicine, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Jacqueline McDermott's work include Ovarian cancer diagnosis and treatment (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (3 papers). Jacqueline McDermott is often cited by papers focused on Ovarian cancer diagnosis and treatment (9 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Cancer Genomics and Diagnostics (3 papers). Jacqueline McDermott collaborates with scholars based in United Kingdom, United States and Canada. Jacqueline McDermott's co-authors include Frances R. Balkwill, Eleni Maniati, Panoraia Kotantaki, Juliana Candido, Cristina Ghirelli, Hemant M. Kocher, Melania Capasso, Stephen A. Beers, Richard K. Grencis and Kathryn J. Else and has published in prestigious journals such as Nature Communications, Cancer Research and Clinical Cancer Research.

In The Last Decade

Jacqueline McDermott

18 papers receiving 366 citations

Peers

Jacqueline McDermott
Kadi Lõhmussaar Netherlands
Mei Cao China
Sanne Samuels Netherlands
Eugene P. Toy United States
Kadi Lõhmussaar Netherlands
Jacqueline McDermott
Citations per year, relative to Jacqueline McDermott Jacqueline McDermott (= 1×) peers Kadi Lõhmussaar

Countries citing papers authored by Jacqueline McDermott

Since Specialization
Citations

This map shows the geographic impact of Jacqueline McDermott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline McDermott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline McDermott more than expected).

Fields of papers citing papers by Jacqueline McDermott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline McDermott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline McDermott. The network helps show where Jacqueline McDermott may publish in the future.

Co-authorship network of co-authors of Jacqueline McDermott

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline McDermott. A scholar is included among the top collaborators of Jacqueline McDermott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline McDermott. Jacqueline McDermott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lakatos, Eszter, Weini Huang, Maximilian Mossner, et al.. (2025). Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control. Cancer Research. 85(18). 3503–3517. 2 indexed citations
3.
McDermott, Jacqueline, Vinothini Rajeeve, Pedro R. Cutillas, et al.. (2024). Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate. Cancer Research Communications. 4(4). 970–985. 7 indexed citations
4.
McNeish, Iain A., et al.. (2024). Homologous recombination deficiency testing in patients with high grade ovarian cancer: factors influencing test success. Future Oncology. 21(3). 341–347. 1 indexed citations
5.
Banerjee, Susana, Gaia Giannone, Andrew R. Clamp, et al.. (2023). Efficacy and Safety of Weekly Paclitaxel Plus Vistusertib vs Paclitaxel Alone in Patients With Platinum-Resistant Ovarian High-Grade Serous Carcinoma. JAMA Oncology. 9(5). 675–675. 13 indexed citations
7.
Miller, Rowan, Florian Laforêts, Panoraia Kotantaki, et al.. (2022). The Tumor Microenvironment of Clear-Cell Ovarian Cancer. Cancer Immunology Research. 10(11). 1326–1339. 21 indexed citations
8.
Mirza, Hasan, Darren Ennis, Philip Smith, et al.. (2022). The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma. Clinical Cancer Research. 28(13). 2911–2922. 28 indexed citations
9.
Montfort, Anne, Anna Piskorz, Anna Supernat, et al.. (2020). Combining measures of immune infiltration shows additive effect on survival prediction in high-grade serous ovarian carcinoma. British Journal of Cancer. 122(12). 1803–1810. 20 indexed citations
10.
Maniati, Eleni, Chiara Berlato, Ganga Gopinathan, et al.. (2020). Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment. Cell Reports. 30(2). 525–540.e7. 66 indexed citations
11.
McDermott, Jacqueline, Amanda Adler, Helen Barker, et al.. (2020). Impact of flash glucose monitoring system in cystic Fibrosis related diabetes. 2774–2774. 1 indexed citations
12.
Provenzano, Elena, Daniel O’Connor, Manuel Rodriguez‐Justo, et al.. (2020). The important role of the histopathologist in clinical trials: challenges and approaches to tackle them. Histopathology. 76(7). 942–949. 12 indexed citations
13.
Candido, Juliana, Jacqueline McDermott, Cristina Ghirelli, et al.. (2019). Discrepancies in the Tumor Microenvironment of Spontaneous and Orthotopic Murine Models of Pancreatic Cancer Uncover a New Immunostimulatory Phenotype for B Cells. Frontiers in Immunology. 10. 542–542. 57 indexed citations
14.
Maniati, Eleni, Chiara Berlato, Ganga Gopinathan, et al.. (2019). Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment. SSRN Electronic Journal. 1 indexed citations
15.
Ledermann, Jonathan A., Michelle Lockley, Nafisa Wilkinson, et al.. (2018). Clear cell ovarian cancer (CCOC): Predicting risk of relapse (ROR). Annals of Oncology. 29. viii348–viii348.
16.
Böhm, Steffen, Peter Ellery, Asma Faruqi, et al.. (2016). The Chemotherapy Response Score (CRS): Interobserver Reproducibility in a Simple and Prognostically Relevant System for Reporting the Histologic Response to Neoadjuvant Chemotherapy in Tuboovarian High-grade Serous Carcinoma. International Journal of Gynecological Pathology. 36(2). 172–179. 24 indexed citations
17.
Bartlett, Thomas E., Kantaraja Chindera, Jacqueline McDermott, et al.. (2016). Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution. Nature Communications. 7(1). 11620–11620. 51 indexed citations
18.
Harb, Wael A., F. Μ. Garner, Jacqueline McDermott, et al.. (2016). Abstract OT2-01-10: A phase 1 study of RAD1901, a novel, orally available, selective estrogen receptor degrader, for the treatment of ER positive advanced breast cancer. Cancer Research. 76(4_Supplement). OT2–1. 2 indexed citations
19.
Mackenzie, Robertson, Aline Talhouk, Sherman Lau, et al.. (2015). Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers. The American Journal of Surgical Pathology. 39(11). 1548–1557. 48 indexed citations
20.
McDermott, Jacqueline, Richard K. Grencis, & Kathryn J. Else. (2001). Leucocyte recruitment during enteric nematode infection. Immunology. 103(4). 505–510. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026